134 related articles for article (PubMed ID: 35429587)
1. Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment.
Khodamoradi M; Tirgar F; Ghazvini H; Rafaiee R; Tamijani SMS; Karimi N; Yadegari A; Khachaki AS; Akhtari J
Neurosci Lett; 2022 May; 779():136634. PubMed ID: 35429587
[TBL] [Abstract][Full Text] [Related]
2. Novel object recognition memory in REM sleep-deprived rats: Role of the cannabinoid CB
Shahveisi K; Farnia V; Khazaie H; Ghazvini H; Nozari M; Khodamoradi M
Behav Brain Res; 2020 Mar; 381():112311. PubMed ID: 31711896
[TBL] [Abstract][Full Text] [Related]
3. Role of Cannabinoid CB
Shahveisi K; Marziyeh Hadi S; Ghazvini H; Khodamoradi M
Chin Med Sci J; 2023 Mar; 38(1):29-37. PubMed ID: 36851888
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
Bortolato M; Frau R; Bini V; Luesu W; Loriga R; Collu M; Gessa GL; Ennas MG; Castelli MP
J Psychiatr Res; 2010 Oct; 44(14):944-55. PubMed ID: 20378129
[TBL] [Abstract][Full Text] [Related]
5. Chronic and acute adenosine A
Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
[TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice.
Yu LL; Wang XY; Zhao M; Liu Y; Li YQ; Li FQ; Wang X; Xue YX; Lu L
Psychopharmacology (Berl); 2009 Jun; 204(2):203-11. PubMed ID: 19148622
[TBL] [Abstract][Full Text] [Related]
7. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
Dang DK; Shin EJ; Mai AT; Jang CG; Nah SY; Jeong JH; Ledent C; Yamamoto T; Nabeshima T; Onaivi ES; Kim HC
Free Radic Biol Med; 2017 Jul; 108():204-224. PubMed ID: 28363605
[TBL] [Abstract][Full Text] [Related]
8. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant.
Paquette JJ; Wang HY; Bakshi K; Olmstead MC
Behav Pharmacol; 2007 Dec; 18(8):767-76. PubMed ID: 17989514
[TBL] [Abstract][Full Text] [Related]
10. Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A
Mouro FM; Köfalvi A; André LA; Baqi Y; Müller CE; Ribeiro JA; Sebastião AM
Neuropharmacology; 2019 Sep; 155():10-21. PubMed ID: 31103616
[TBL] [Abstract][Full Text] [Related]
11. Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats.
Camarasa J; Rodrigo T; Pubill D; Escubedo E
Pharmacol Res; 2010 Nov; 62(5):450-6. PubMed ID: 20553881
[TBL] [Abstract][Full Text] [Related]
12. WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids.
Barna I; Soproni K; Arszovszki A; Csabai K; Haller J
Behav Pharmacol; 2007 Sep; 18(5-6):515-20. PubMed ID: 17762520
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.
Loewinger GC; Beckert MV; Tejeda HA; Cheer JF
Neuropharmacology; 2012 Jun; 62(7):2192-201. PubMed ID: 22306525
[TBL] [Abstract][Full Text] [Related]
15. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
Hasanein P; Teimuri Far M
Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
[TBL] [Abstract][Full Text] [Related]
16. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.
Zhang RS; He Z; Jin WD; Wang R
Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.
Morra JT; Glick SD; Cheer JF
Neuropharmacology; 2012 Sep; 63(4):565-74. PubMed ID: 22609048
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 receptor mediates METH-induced electrophysiological and morphological alterations in cerebellum Purkinje cells.
Ramshini E; Sheykhzade M; Dabiri S; Shabani M
Hum Exp Toxicol; 2021 Jun; 40(6):940-951. PubMed ID: 33249856
[TBL] [Abstract][Full Text] [Related]
19. Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits.
Subbanna S; Shivakumar M; Psychoyos D; Xie S; Basavarajappa BS
J Neurosci; 2013 Apr; 33(15):6350-66. PubMed ID: 23575834
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid CB
He XH; Jordan CJ; Vemuri K; Bi GH; Zhan J; Gardner EL; Makriyannis A; Wang YL; Xi ZX
Acta Pharmacol Sin; 2019 Mar; 40(3):365-373. PubMed ID: 29967454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
